Celgene Corp (NASDAQ:CELG)

79.54
Delayed Data
As of 4:00pm ET
 +1.88 / +2.42%
Today’s Change
74.13
Today|||52-Week Range
147.17
-23.78%
Year-to-Date

Today’s Trading

Previous close77.66
Today’s open78.78
Day’s range78.51 - 79.89
Volume8,541,563
Average volume (3 months)7,629,678
Market cap$61.8B
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+46.18%
Earnings growth (this year)+14.82%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+17.40%
P/E ratio22.2
Price/Sales6.58
Price/Book9.36

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.15-0.37%
BMYBristol-Myers Squibb+0.19+0.36%
NVONovo Nordisk-0.17-0.35%
ABBVAbbVie-2.46-2.33%
Data as of 4:02pm ET, 05/24/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$2.11
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Executive VP, Chief Financial &
Accounting Officer
Peter N. Kellogg
Corporate headquarters
Summit, New Jersey

Forecasts